Načítá se...

Trastuzumab in the management of early and advanced stage breast cancer

Trastuzumab is a monoclonal humanized antibody that has revolutionized the treatment of patients with Her2-positive breast cancer. Already well established in advanced stage disease, the substance was recently introduced in the adjuvant setting, reducing disease recurrences by more than 50% and mort...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Bartsch, Rupert, Wenzel, Catharina, Steger, Guenther G
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2007
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2721347/
https://ncbi.nlm.nih.gov/pubmed/19707345
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!